Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas S Johnson

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Future Medicinal Chemistry|October 30, 2015
Recent developments and applications of clickable photoprobes in medicinal chemistry and chemical biologyDavid J Lapinsky, Douglas S Johnson
Advances in Chronic Kidney Disease|December 12, 2018
Leading Integrated Kidney Care Entities of the FutureDouglas S Johnson, Klemens B Meyer
Clinical Journal of the American Society of Nephrology : CJASN|October 10, 2020
Challenges with Providing Hospice Care for Patients Undergoing Long-Term DialysisJane O Schell, Douglas S Johnson
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2019
Integrated Care for People with Kidney Disease: The Perspective of a Nonprofit Dialysis ProviderDouglas S Johnson, Klemens B Meyer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 18, 2018
Delaying and Averting Dialysis Treatment: Patient Protection or Moral Hazard?Douglas S Johnson, Klemens B Meyer
Cell Chemical Biology|November 18, 2017
Bond with Me If You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A ComplexDouglas S Johnson, Jaimeen D Majmudar
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2015
Infection prevention and the medical director: uncharted territoryToros Kapoian, Klemens B Meyer, Douglas S Johnson
Expert Opinion on Drug Discovery|June 15, 2010
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disordersKay Ahn, Douglas S Johnson, Benjamin F Cravatt
Future Medicinal Chemistry|July 20, 2010
Strategies for discovering and derisking covalent, irreversible enzyme inhibitorsDouglas S Johnson, Eranthie Weerapana, Benjamin F Cravatt
Current Opinion in Nephrology and Hypertension|September 30, 2015
Nutrition, vitamin D, and health outcomes in hemodialysis: time for a feeding frenzy?Daniel E Weiner, Toros Kapoian, Douglas S Johnson
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Future Medicinal Chemistry|October 30, 2015
Recent developments and applications of clickable photoprobes in medicinal chemistry and chemical biologyDavid J Lapinsky, Douglas S Johnson
Advances in Chronic Kidney Disease|December 12, 2018
Leading Integrated Kidney Care Entities of the FutureDouglas S Johnson, Klemens B Meyer
Clinical Journal of the American Society of Nephrology : CJASN|October 10, 2020
Challenges with Providing Hospice Care for Patients Undergoing Long-Term DialysisJane O Schell, Douglas S Johnson
Clinical Journal of the American Society of Nephrology : CJASN|January 31, 2019
Integrated Care for People with Kidney Disease: The Perspective of a Nonprofit Dialysis ProviderDouglas S Johnson, Klemens B Meyer
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 18, 2018
Delaying and Averting Dialysis Treatment: Patient Protection or Moral Hazard?Douglas S Johnson, Klemens B Meyer
Cell Chemical Biology|November 18, 2017
Bond with Me If You Can! Natural Product, Covalent Ligand, and Reactivity-Based Probe Compete for Cysteine in PP2A ComplexDouglas S Johnson, Jaimeen D Majmudar
Clinical Journal of the American Society of Nephrology : CJASN|February 25, 2015
Infection prevention and the medical director: uncharted territoryToros Kapoian, Klemens B Meyer, Douglas S Johnson
Expert Opinion on Drug Discovery|June 15, 2010
Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disordersKay Ahn, Douglas S Johnson, Benjamin F Cravatt
Future Medicinal Chemistry|July 20, 2010
Strategies for discovering and derisking covalent, irreversible enzyme inhibitorsDouglas S Johnson, Eranthie Weerapana, Benjamin F Cravatt
Current Opinion in Nephrology and Hypertension|September 30, 2015
Nutrition, vitamin D, and health outcomes in hemodialysis: time for a feeding frenzy?Daniel E Weiner, Toros Kapoian, Douglas S Johnson
Pageof 7